Aamir Ahmad holds a PhD in Biochemistry from AMU, India, and completed his post-doctoral training at the NCI, NIH, MD, USA. He is currently a Scientist at University of Alabama at Birmingham, USA. His research investigates the epigenetic basis of cancer drug resistance and metastasis, with a focus on non-coding RNAs, cancer stem cells and the tumor microenvironment. Dr Ahmad has been an Editorial Board Member for Scientific Reports since 2017.